A study of the incidence of malignancy and clinicopathological correlation of incidence of malignancy in peptic perforation disease

Jishnu Chatterjee; Manju Singh; Prachi Shrimor; Jayanti Chandrakar

doi:10.18203/2349-2902.isj20250568

Authors

Jishnu Chatterjee Department of General Surgery, Pandit Jawaharlal Nehru Memorial Medical College and Dr. Bhim Rao Ambedkar Memorial Hospital, Raipur, Chhattisgarh, India
Manju Singh Department of General Surgery, Pandit Jawaharlal Nehru Memorial Medical College and Dr. Bhim Rao Ambedkar Memorial Hospital, Raipur, Chhattisgarh, India
Prachi Shrimor Department of General Surgery, Pandit Jawaharlal Nehru Memorial Medical College and Dr. Bhim Rao Ambedkar Memorial Hospital, Raipur, Chhattisgarh, India
Jayanti Chandrakar Department of Pathology, Pandit Jawaharlal Nehru Memorial Medical College and Dr. Bhim Rao Ambedkar Memorial Hospital, Raipur, Chhattisgarh, India

DOI:

https://doi.org/10.18203/2349-2902.isj20250568

Keywords:

Adenocarcinoma, Gastric perforation, Malignancy

Abstract

Background: Gastrointestinal perforation, a common emergency in surgery, often results from peptic ulcer disease but can also be caused by gastric cancer. Peptic ulcers, with a lifetime risk of 10%, are more prevalent in developing countries and linked to factors like H. pylori infection, NSAID use, smoking, and stress. Complications include bleeding, perforation, obstruction, and cancer. Perforation leads to peritonitis, requiring treatment via perforation closure. Although gastric cancer accounts for 10-16% of perforations, many patients don't undergo post-operative biopsy, potentially missing cancer diagnoses. This study aimed to determine the true incidence of malignancy in perforation cases as well as in specific demographics and identify contributing factors.

Methods: The present study was aimed at determining the true incidence of malignancy in perforation cases as well as in specific demographics and identify contributing factors. Biopsies taken from the margins of gastric (antral) perforation during the operation, were subjected to histopathological examination.

Results: Our study found only 1 case of perforation in a male patient, in the 61-70-year age bracket with history of both smoking as well as alcohol, to have an associated malignancy.

Conclusions: The incidence of malignancy in gastric perforation is very low and as a result, often goes undiagnosed, resulting in lack of appropriate treatment of the underlying cancer.

Metrics

Metrics Loading ...

References

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. DOI: https://doi.org/10.3322/caac.21492

Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009;125(3):666-73. DOI: https://doi.org/10.1002/ijc.24290

Gustafson J, Welling D. “No acid, no ulcer”- 100 years later: a review of the history of peptic ulcer disease. J Am Coll Surg. 2010;210(1):110-6. DOI: https://doi.org/10.1016/j.jamcollsurg.2009.08.014

Sarker SK, Sinha VK, Chaudhry R, Maudar KK. Gastric cancer: a critical analysis of surgical treatment and long term survival. J Indian Med Assoc. 1992;90(3):61-4.

Cortese AF, Zahn D, Cornell GN. Perforation in gastric malignancy. J Surg Oncol. 1972;4(3):190-206 DOI: https://doi.org/10.1002/jso.2930040304

Santoro E. The history of gastric cancer: legends and chronicles. Gastric Cancer. 2005;8(2):71. DOI: https://doi.org/10.1007/s10120-005-0325-8

Bhaskar S, Kumari P, Sinha DK. Incidence of malignancy in gastric/antral perforation. Int Surg J. 2019;6(9):3347-52.

Ghosh BC, Gangopadhyay A, Ghosh G. Assessment of recent epidemiological trends in peptic ulcer perforation patients in an eastern Indian tertiary hospital. Asian J Med Sci. 2018;9(6):68-75. DOI: https://doi.org/10.3126/ajms.v9i6.20858

Malfertheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet. 2009;374(9699):1449-61. DOI: https://doi.org/10.1016/S0140-6736(09)60938-7

Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388(10060):2654-64. DOI: https://doi.org/10.1016/S0140-6736(16)30354-3

De DD, Roychoudhury S. To be or not to be: the host genetic factor and beyond in Helicobacter pylori mediated gastro-duodenal diseases. World J Gastroenterol. 2015;21(10):2883. DOI: https://doi.org/10.3748/wjg.v21.i10.2883

Fukayama M, Ushiku T. Epstein-Barr virus-associated gastric carcinoma. Pathol Res Pract. 2011;207(9):529-37. DOI: https://doi.org/10.1016/j.prp.2011.07.004

Corsonello A, Lattanzio F, Bustacchini S, Garasto S, Cozza A, Schepisi R, et al. Adverse events of proton pump inhibitors: potential mechanisms. Curr Drug Metab. 2018;19(2):142-54. DOI: https://doi.org/10.2174/1389200219666171207125351

McColl KE, El-Omar E, Gillen D. Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy. Br Med Bull. 1998;54(1):121-38. DOI: https://doi.org/10.1093/oxfordjournals.bmb.a011663

Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, et al. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol. 2012;19(2):677-83. DOI: https://doi.org/10.1245/s10434-011-1983-x

Tahara E. Genetic pathways of two types of gastric cancer. IARC Sci Pub. 2004;(157):327-49.

Chen YC, Fang WL, Wang RF, Liu CA, Yang MH, Lo SS, et al. Clinicopathological variation of Lauren classification in gastric cancer. Pathol Oncol Res. 2016;22(1):197-202. DOI: https://doi.org/10.1007/s12253-015-9996-6

Berlth F, Bollschweiler E, Drebber U, Hoelscher AH, Moenig S. Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value. World J Gastroenterol. 2014;20(19):5679. DOI: https://doi.org/10.3748/wjg.v20.i19.5679

Sohn BH, Hwang JE, Jang HJ, Lee HS, Oh SC, Shim JJ, et al. Clinical significance of four molecular subtypes of gastric cancer identified by the cancer genome atlas project. Clin Cancer Res. 2017;23(15):4441-9. DOI: https://doi.org/10.1158/1078-0432.CCR-16-2211

Van Cutsem E, Kang Y, Chung H, Shen L, Sawaki A, Lordick F, et al. Efficacy results from the ToGA trial: a phase III study of trastuzumab added to standard chemotherapy in first-line HER2-positive advanced gastric cancer. J clin Oncol. 2009;27(18):LBA4509. DOI: https://doi.org/10.1200/jco.2009.27.18_suppl.lba4509

Ergul E, Gozetlik EO. Emergency spontaneous gastric perforations: ulcus versus cancer. Langenbeck’s Arch Surg. 2009;394:643-6. DOI: https://doi.org/10.1007/s00423-008-0331-5

Bhaskar S, Kumari P, Sinha DK. Incidence of malignancy in gastric/antral perforation. Int Surg J. 2019;6(9):3347-52. DOI: https://doi.org/10.18203/2349-2902.isj20194077

Roviello F, Rossi S, Marrelli D, De Manzoni G, Pedrazzani C, Morgagni P, et al. Perforated gastric carcinoma: a report of 10 cases and review of the literature. World J Surg Oncol. 2006;4(1):1-6. DOI: https://doi.org/10.1186/1477-7819-4-19

Kotan C, Sumer A, Baser M, Kızıltan R, Carparlar MA. An analysis of 13 patients with perforated gastric carcinoma: a surgeon’s nightmare? World J Emerg Surg. 2008;3(1):1-6. DOI: https://doi.org/10.1186/1749-7922-3-17

Ignjatovic N, Stojanov D, Djordjevic M, Ignjatovic J, Stojanov DB, Milojkovic B. Perforation of gastric cancer-what should the surgeon do? Bosnian J Basic Med Sci. 2016;16(3):222. DOI: https://doi.org/10.17305/bjbms.2016.1020

Trédaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and meta‐analysis. Int J Cancer. 1997;72(4):565-73. DOI: https://doi.org/10.1002/(SICI)1097-0215(19970807)72:4<565::AID-IJC3>3.0.CO;2-O

Tan KK, Quek TJ, Wong N, Li KK, Lim KH. Emergency surgery for perforated gastric malignancy: an institution’s experience and review of the literature. J Gastroint Oncol. 2011;2(1):13.